Stefano Cianfarani researcher ORCID ID = 0000-0002-2580-8781
Cianfarani, Stefano
Cianfarani, S.
VIAF ID: 60178162 (Personal)
Permalink: http://viaf.org/viaf/60178162
Preferred Forms
-
- 100 1 _ ‡a Cianfarani, Stefano
-
- 100 1 _ ‡a Cianfarani, Stefano
-
- 100 1 _ ‡a Cianfarani, Stefano
- 100 1 _ ‡a Cianfarani, Stefano
-
- 100 0 _ ‡a Stefano Cianfarani ‡c researcher ORCID ID = 0000-0002-2580-8781
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Advanced therapies in pediatric endocrinology and diabetology : workshop, Rome, October 27-28, 2014 | |
The Challenge of Defining and Investigating the Causes of Idiopathic Short Stature and Finding an Effective Therapy | |
The Challenge of Growth Hormone Deficiency Diagnosis and Treatment during the Transition from Puberty into Adulthood. | |
Collagen cross-links and early postnatal growth in newborns with intrauterine growth retardation | |
Complex cytogenetic rearrangement of chromosome 8q in a case of Ambras syndrome | |
Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial | |
Early Detection, Referral, Investigation, and Diagnosis of Children with Growth Disorders | |
Early Glucose Derangement Detected by Continuous Glucose Monitoring and Progression of Liver Fibrosis in Nonalcoholic Fatty Liver Disease: An Independent Predictive Factor? | |
Early retesting by GHRH + arginine test shows normal GH response in most children with idiopathic GH deficiency | |
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes | |
Endocrine Disruptors and Child Health: New Insights. | |
Epigenetic changes predisposing to type 2 diabetes in intrauterine growth retardation | |
Epigenetic mechanisms elicited by nutrition in early life | |
Epigenetics and In Utero Acquired Predisposition to Metabolic Disease | |
The exposure to uteroplacental insufficiency is associated with activation of unfolded protein response in postnatal life. | |
Exposure to uteroplacental insufficiency reduces the expression of signal transducer and activator of transcription 3 and proopiomelanocortin in the hypothalamus of newborn rats | |
Expression and down-regulation by retinoic acid of IGF binding protein-2 and -4 in medium from human neuroblastoma cells. | |
Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD. | |
FGF17, a gene involved in cerebellar development, is downregulated in a patient with Dandy-Walker malformation carrying a de novo 8p deletion. | |
Foetal origins of adult diseases: just a matter of stem cell number? | |
Functional Significance and Predictive Value of MicroRNAs in Pediatric Obesity: Tiny Molecules with Huge Impact? | |
GH assessment and three years' hGH therapy in girls with Turner syndrome | |
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults | |
GHD Diagnostics in Europe and the US: An Audit of National Guidelines and Practice | |
Glucose does not influence the insulin-like growth factor (JGF) binding to carrier proteins (IGFBPs): analysis of rat and human serum by western ligand blotting | |
Growth hormone treatment and somatomedin-C levels | |
How far should indications for growth hormone expand? | |
IGF-I and IGF-binding protein-1 are related to cortisol in human cord blood. | |
IGF-I and IGF binding proteins : basic research and clinical management | |
The impact of growth hormone therapy on adult height in noonan syndrome: a systematic review | |
The impact of IGF-I, puberty and obesity on early retinopathy in children: a cross-sectional study | |
Impact of uteroplacental insufficiency on ovarian follicular pool in the rat | |
Improving care of children with endocrine diseases | |
In vitro effects of growth hormone (GH) and insulin-like growth factor I and II (IGF-I and -II) on chromosome fragility and p53 protein expression in human lymphocytes | |
Insulin-like growth factor binding proteins in follicular fluid from normal dominant and cohort follicles, polycystic and multicystic ovaries | |
Isolation and characterization of omental adipose progenitor cells in children: a potential tool to unravel the pathogenesis of metabolic syndrome | |
Late effects of disturbed IGF signaling in congenital diseases | |
The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases | |
Long-term safety of growth hormone therapy: still a controversial issue | |
Low birth weight for gestational age associates with reduced glucose concentrations at birth, infancy and childhood | |
Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. | |
Marked left ventricular hypertrophy mimicking hypertrophic cardiomyopathy associated with steroid therapy for congenital adrenal hyperplasia | |
Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans | |
Neonatal identification of pituitary aplasia: a life-saving diagnosis. Review of five cases | |
Neuroblastoma and insulin-like growth factor system. New insights and clinical perspectives. | |
Neuroendocrine complications of central nervous system malformations | |
New Sections for the New Year | |
Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment | |
Oral glucose effectiveness and metabolic risk in obese children and adolescents | |
Personalized approach to growth hormone treatment: clinical use of growth prediction models. | |
Pilot study on circulating miRNA signature in children with obesity born small for gestational age and appropriate for gestational age | |
A position effect on TRPS1 is associated with Ambras syndrome in humans and the Koala phenotype in mice | |
Postnatal onset of severe growth retardation after in utero exposure to carbamazepine and phenobarbital: a case report | |
Predictors of blood pressure at 7-13 years: The "new millennium baby" study | |
Premature ovarian failure, absence of pubic and axillary hair with de novo 46,X,t(X;15)(q24;q26.3) | |
Preterm infants with severe extrauterine growth retardation (EUGR) are at high risk of growth impairment during childhood. | |
Primary empty sella and endocrinopathies in childhood: high prevalence among children with precocious puberty | |
Programming, metabolic syndrome, and NAFLD: the challenge of transforming a vicious cycle into a virtuous cycle | |
Residual β-cell mass influences growth of prepubertal children with type 1 diabetes. | |
The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life. | |
Responses to GHRH plus arginine test are more concordant with IGF-I circulating levels than responses to arginine and clonidine provocative tests | |
Review of growth hormone randomized controlled trials in children with idiopathic short stature | |
Risk of cancer in patients treated with recombinant human growth hormone in childhood | |
Routine screening by brain magnetic resonance imaging is not indicated in every girl with onset of puberty between the ages of 6 and 8 years | |
Serum Levels of Polybrominated Diphenyl Ethers in Girls with Premature Thelarche | |
Sexual dimorphism in growth and insulin-like growth factor-I in children with type 1 diabetes mellitus. | |
Tall stature in familial glucocorticoid deficiency | |
Usefulness of serum insulin-like growth factor I assessment in the diagnosis of childhood-onset growth hormone deficiency. | |
Uteroplacental insufficiency down regulates insulin receptor and affects expression of key enzymes of long-chain fatty acid (LCFA) metabolism in skeletal muscle at birth | |
Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. | |
Water Balance and 'Salt Wasting' in the First Year of Life: The Role of Aldosterone-Signaling Defects | |
What is the rationale for growth hormone therapy in Turner's syndrome? |